Pre-order Enquiry
Request Free Sample
Global β1 Adrenoceptor Agonists Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18541769 | Publishing Date : 14-Jun-2021 | No. of pages : 113
Detailed TOC of Global β1 Adrenoceptor Agonists Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of β1 Adrenoceptor Agonists1.1 β1 Adrenoceptor Agonists Market Overview
1.1.1 β1 Adrenoceptor Agonists Product Scope
1.1.2 β1 Adrenoceptor Agonists Market Status and Outlook
1.2 Global β1 Adrenoceptor Agonists Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global β1 Adrenoceptor Agonists Market Size by Region (2016-2027)
1.4 Global β1 Adrenoceptor Agonists Historic Market Size by Region (2016-2021)
1.5 Global β1 Adrenoceptor Agonists Market Size Forecast by Region (2022-2027)
1.6 Key Regions, β1 Adrenoceptor Agonists Market Size (2016-2027)
1.6.1 North America β1 Adrenoceptor Agonists Market Size (2016-2027)
1.6.2 Europe β1 Adrenoceptor Agonists Market Size (2016-2027)
1.6.3 Asia-Pacific β1 Adrenoceptor Agonists Market Size (2016-2027)
1.6.4 Latin America β1 Adrenoceptor Agonists Market Size (2016-2027)
1.6.5 Middle East & Africa β1 Adrenoceptor Agonists Market Size (2016-2027)
2 β1 Adrenoceptor Agonists Market Overview by Type
2.1 Global β1 Adrenoceptor Agonists Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global β1 Adrenoceptor Agonists Historic Market Size by Type (2016-2021)
2.3 Global β1 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027)
2.4 Dobutamine
2.5 Denopamine
2.6 Xamoterol
2.7 Others
3 β1 Adrenoceptor Agonists Market Overview by Application
3.1 Global β1 Adrenoceptor Agonists Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global β1 Adrenoceptor Agonists Historic Market Size by Application (2016-2021)
3.3 Global β1 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027)
3.4 Chronic Heart Failure
3.5 Myocardial Infarction
3.6 Postoperative Hypotension
3.7 Others
4 β1 Adrenoceptor Agonists Competition Analysis by Players
4.1 Global β1 Adrenoceptor Agonists Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β1 Adrenoceptor Agonists as of 2020)
4.3 Date of Key Players Enter into β1 Adrenoceptor Agonists Market
4.4 Global Top Players β1 Adrenoceptor Agonists Headquarters and Area Served
4.5 Key Players β1 Adrenoceptor Agonists Product Solution and Service
4.6 Competitive Status
4.6.1 β1 Adrenoceptor Agonists Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Ivax Pharmaceuticals
5.1.1 Ivax Pharmaceuticals Profile
5.1.2 Ivax Pharmaceuticals Main Business
5.1.3 Ivax Pharmaceuticals β1 Adrenoceptor Agonists Products, Services and Solutions
5.1.4 Ivax Pharmaceuticals β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.1.5 Ivax Pharmaceuticals Recent Developments
5.2 Physicians Total Care
5.2.1 Physicians Total Care Profile
5.2.2 Physicians Total Care Main Business
5.2.3 Physicians Total Care β1 Adrenoceptor Agonists Products, Services and Solutions
5.2.4 Physicians Total Care β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.2.5 Physicians Total Care Recent Developments
5.3 Baxter Healthcare
5.5.1 Baxter Healthcare Profile
5.3.2 Baxter Healthcare Main Business
5.3.3 Baxter Healthcare β1 Adrenoceptor Agonists Products, Services and Solutions
5.3.4 Baxter Healthcare β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi β1 Adrenoceptor Agonists Products, Services and Solutions
5.4.4 Sanofi β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.4.5 Sanofi Recent Developments
5.5 Teva Canada
5.5.1 Teva Canada Profile
5.5.2 Teva Canada Main Business
5.5.3 Teva Canada β1 Adrenoceptor Agonists Products, Services and Solutions
5.5.4 Teva Canada β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.5.5 Teva Canada Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer β1 Adrenoceptor Agonists Products, Services and Solutions
5.6.4 Pfizer β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.6.5 Pfizer Recent Developments
5.7 Bedford Laboratories
5.7.1 Bedford Laboratories Profile
5.7.2 Bedford Laboratories Main Business
5.7.3 Bedford Laboratories β1 Adrenoceptor Agonists Products, Services and Solutions
5.7.4 Bedford Laboratories β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.7.5 Bedford Laboratories Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis β1 Adrenoceptor Agonists Products, Services and Solutions
5.8.4 Novartis β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.8.5 Novartis Recent Developments
5.9 Sterimax
5.9.1 Sterimax Profile
5.9.2 Sterimax Main Business
5.9.3 Sterimax β1 Adrenoceptor Agonists Products, Services and Solutions
5.9.4 Sterimax β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.9.5 Sterimax Recent Developments
5.10 Teligent
5.10.1 Teligent Profile
5.10.2 Teligent Main Business
5.10.3 Teligent β1 Adrenoceptor Agonists Products, Services and Solutions
5.10.4 Teligent β1 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021)
5.10.5 Teligent Recent Developments
6 North America
6.1 North America β1 Adrenoceptor Agonists Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe β1 Adrenoceptor Agonists Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America β1 Adrenoceptor Agonists Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa β1 Adrenoceptor Agonists Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 β1 Adrenoceptor Agonists Market Dynamics
11.1 β1 Adrenoceptor Agonists Industry Trends
11.2 β1 Adrenoceptor Agonists Market Drivers
11.3 β1 Adrenoceptor Agonists Market Challenges
11.4 β1 Adrenoceptor Agonists Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global β1 Adrenoceptor Agonists Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market β1 Adrenoceptor Agonists Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global β1 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global β1 Adrenoceptor Agonists Market Size Share by Region (2016-2021)
Table 4. Global β1 Adrenoceptor Agonists Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global β1 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027)
Table 6. Global β1 Adrenoceptor Agonists Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global β1 Adrenoceptor Agonists Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global β1 Adrenoceptor Agonists Revenue Market Share by Type (2016-2021)
Table 9. Global β1 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global β1 Adrenoceptor Agonists Revenue Market Share by Type (2022-2027)
Table 11. Global β1 Adrenoceptor Agonists Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global β1 Adrenoceptor Agonists Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global β1 Adrenoceptor Agonists Revenue Market Share by Application (2016-2021)
Table 14. Global β1 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global β1 Adrenoceptor Agonists Revenue Market Share by Application (2022-2027)
Table 16. Global β1 Adrenoceptor Agonists Revenue (US$ Million) by Players (2016-2021)
Table 17. Global β1 Adrenoceptor Agonists Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β1 Adrenoceptor Agonists as of 2020)
Table 19. Date of Key Manufacturers Enter into β1 Adrenoceptor Agonists Market
Table 20. Global β1 Adrenoceptor Agonists Top Players Headquarters and Area Served
Table 21. β1 Adrenoceptor Agonists Product Solution and Service
Table 22. Global β1 Adrenoceptor Agonists Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Ivax Pharmaceuticals Basic Information List
Table 25. Ivax Pharmaceuticals Description and Business Overview
Table 26. Ivax Pharmaceuticals β1 Adrenoceptor Agonists Products, Services and Solutions
Table 27. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Ivax Pharmaceuticals (2016-2021)
Table 28. Ivax Pharmaceuticals Recent Developments
Table 29. Physicians Total Care Basic Information List
Table 30. Physicians Total Care Description and Business Overview
Table 31. Physicians Total Care β1 Adrenoceptor Agonists Products, Services and Solutions
Table 32. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Physicians Total Care (2016-2021)
Table 33. Physicians Total Care Recent Developments
Table 34. Baxter Healthcare Basic Information List
Table 35. Baxter Healthcare Description and Business Overview
Table 36. Baxter Healthcare β1 Adrenoceptor Agonists Products, Services and Solutions
Table 37. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Baxter Healthcare (2016-2021)
Table 38. Baxter Healthcare Recent Developments
Table 39. Sanofi Basic Information List
Table 40. Sanofi Description and Business Overview
Table 41. Sanofi β1 Adrenoceptor Agonists Products, Services and Solutions
Table 42. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Sanofi (2016-2021)
Table 43. Sanofi Recent Developments
Table 44. Teva Canada Basic Information List
Table 45. Teva Canada Description and Business Overview
Table 46. Teva Canada β1 Adrenoceptor Agonists Products, Services and Solutions
Table 47. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Teva Canada (2016-2021)
Table 48. Teva Canada Recent Developments
Table 49. Pfizer Basic Information List
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer β1 Adrenoceptor Agonists Products, Services and Solutions
Table 52. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Pfizer (2016-2021)
Table 53. Pfizer Recent Developments
Table 54. Bedford Laboratories Basic Information List
Table 55. Bedford Laboratories Description and Business Overview
Table 56. Bedford Laboratories β1 Adrenoceptor Agonists Products, Services and Solutions
Table 57. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Bedford Laboratories (2016-2021)
Table 58. Bedford Laboratories Recent Developments
Table 59. Novartis Basic Information List
Table 60. Novartis Description and Business Overview
Table 61. Novartis β1 Adrenoceptor Agonists Products, Services and Solutions
Table 62. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Novartis (2016-2021)
Table 63. Novartis Recent Developments
Table 64. Sterimax Basic Information List
Table 65. Sterimax Description and Business Overview
Table 66. Sterimax β1 Adrenoceptor Agonists Products, Services and Solutions
Table 67. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Sterimax (2016-2021)
Table 68. Sterimax Recent Developments
Table 69. Teligent Basic Information List
Table 70. Teligent Description and Business Overview
Table 71. Teligent β1 Adrenoceptor Agonists Products, Services and Solutions
Table 72. Revenue (US$ Million) in β1 Adrenoceptor Agonists Business of Teligent (2016-2021)
Table 73. Teligent Recent Developments
Table 74. North America β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific β1 Adrenoceptor Agonists Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2016-2021)
Table 81. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2022-2027)
Table 82. Latin America β1 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa β1 Adrenoceptor Agonists Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa β1 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 86. β1 Adrenoceptor Agonists Market Trends
Table 87. β1 Adrenoceptor Agonists Market Drivers
Table 88. β1 Adrenoceptor Agonists Market Challenges
Table 89. β1 Adrenoceptor Agonists Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global β1 Adrenoceptor Agonists Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global β1 Adrenoceptor Agonists Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global β1 Adrenoceptor Agonists Market Share by Regions: 2021 VS 2027
Figure 4. Global β1 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America β1 Adrenoceptor Agonists Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa β1 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global β1 Adrenoceptor Agonists Market Size Share by Type in 2021 & 2027
Figure 11. Dobutamine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Denopamine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Xamoterol Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Global β1 Adrenoceptor Agonists Market Size Share by Application in 2021 & 2027
Figure 16. Chronic Heart Failure Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Myocardial Infarction Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Postoperative Hypotension Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. β1 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Top 5 and Top 10 Players β1 Adrenoceptor Agonists Market Share in 2020
Figure 22. North America β1 Adrenoceptor Agonists Market Share by Country (2016-2027)
Figure 23. United States β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 24. Canada β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 25. Germany β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 26. France β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 27. U.K. β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 28. Italy β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 29. Russia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 30. Nordic β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 31. Rest of Europe β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 32. Asia-Pacific β1 Adrenoceptor Agonists Market Share by Region (2016-2027)
Figure 33. China β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 34. Japan β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 35. South Korea β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 36. Southeast Asia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 37. India β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 38. Australia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 39. Rest of Asia-Pacific β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 40. Latin America β1 Adrenoceptor Agonists Market Share by Country (2016-2027)
Figure 41. Mexico β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 42. Brazil β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 43. Rest of Latin America β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 44. Middle East & Africa β1 Adrenoceptor Agonists Market Share by Country (2016-2027)
Figure 45. Turkey β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 46. Saudi Arabia β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 47. UAE β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 48. Rest of Middle East & Africa β1 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Keyplayers in Global β1 Adrenoceptor Agonists Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Ivax PharmaceuticalsPhysicians Total Care
Baxter Healthcare
Sanofi
Teva Canada
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
Request Sample
Request Discount
